{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:31:43Z","timestamp":1792153903290,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Science and Technology for Viral Hemorrhagic Fevers","award":["573739\/2008-0"],"award-info":[{"award-number":["573739\/2008-0"]}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["301421\/2010-2"],"award-info":[{"award-number":["301421\/2010-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["401558\/2013-4"],"award-info":[{"award-number":["401558\/2013-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["457664\/2013-4"],"award-info":[{"award-number":["457664\/2013-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalofclinicalvirology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jcv.2014.08.030","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T18:17:39Z","timestamp":1414174659000},"page":"160-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":667,"special_numbering":"C","title":["Yellow fever"],"prefix":"10.1016","volume":"64","author":[{"given":"Thomas P.","family":"Monath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro F.C.","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2014.08.030_bib0005","series-title":"Vaccines","first-page":"870","article-title":"Yellow fever vaccine","author":"Monath","year":"2012"},{"key":"10.1016\/j.jcv.2014.08.030_bib0010","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1590\/S0034-89102010005000046","article-title":"Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas","volume":"44","author":"Vasconcelos","year":"2010","journal-title":"Rev Saude P\u00fablica"},{"key":"10.1016\/j.jcv.2014.08.030_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ento.52.110405.091454","article-title":"Yellow fever: a disease that has yet to be conquered","volume":"52","author":"Barrett","year":"2007","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(11)70147-5","article-title":"The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever","volume":"11","author":"Jentes","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0025","first-page":"465","article-title":"Yellow fever surveillance and outbreak response: revision of case definitions, October 2010","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2014.08.030_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jmv.21606","article-title":"Detection of a new yellow fever virus lineage within the South American genotype I in Brazil","volume":"82","author":"Souza","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiologic characteristics of yellow fever in Brazil: analysis of reported cases, 1998\u20132002","volume":"101","author":"Tuboi","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/S0036-46652013000100008","article-title":"Yellow fever epizootics in non-human primates, S\u00e3o Paulo state, Brazil, 2008\u20132009","volume":"55","author":"Moreno","year":"2013","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jcv.2014.08.030_bib0050","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.ppat.0030075","article-title":"Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas","volume":"3","author":"Bryant","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcv.2014.08.030_bib0055","series-title":"YF risk mapping: methodology and results for the Americas. PAHO\\HSD\\IR viral diseases","author":"N\u00e1jera","year":"2013"},{"key":"10.1016\/j.jcv.2014.08.030_bib0060","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1089\/vbz.2011.0730","article-title":"Isolation of yellow fever virus from mosquitoes in Misiones province, Argentina","volume":"12","author":"Goenaga","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0065a","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3201\/eid1009.040197","article-title":"Genetic divergence and dispersal of yellow fever virus, Brazil","volume":"10","author":"Vasconcelos","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.jcv.2014.08.030_sbref0065b","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0035-9203(03)90023-X","article-title":"Isolations of yellow fever virus from Haemagogus leucocelaenus in Rio Grande do Sul State, Brazil, in the Southern Cone","volume":"97","author":"Vasconcelos","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.jcv.2014.08.030_sbref0070a","doi-asserted-by":"crossref","first-page":"e2741","DOI":"10.1371\/journal.pntd.0002741","article-title":"Surveillance for yellow fever virus in non-human primates in Southern Brazil, 2001\u20132011: a tool for prioritizing human populations for vaccination","volume":"8","author":"Almeida","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.jcv.2014.08.030_sbref0070b","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3201\/eid1612.100608","article-title":"Yellow fever virus isolation from Haemagogus leucocelaenus and Aedes serratus mosquitoes: southern Brazil, 2008","volume":"16","author":"Cardoso","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jcv.2014.08.030_bib0085","doi-asserted-by":"crossref","first-page":"e2740","DOI":"10.1371\/journal.pntd.0002740","article-title":"Yellow fever outbreaks in unvaccinated populations, Brazil, 2008\u20132009","volume":"8","author":"Romano","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1300772","article-title":"Yellow fever outbreak in Sudan","volume":"368","author":"Markoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2014.08.030_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data","author":"Garske","year":"2014","journal-title":"PLoS Med"},{"issue":"14","key":"10.1016\/j.jcv.2014.08.030_bib0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow fever: a decade of reemergence","volume":"276","author":"Robertson","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2014.08.030_bib0105","unstructured":"World Health Organization. Epidemiology of yellow fever in the African region. WHO\/OR-02 March 2012."},{"key":"10.1016\/j.jcv.2014.08.030_bib0110","first-page":"178","article-title":"Surveillance of yellow fever in Nigeria, 1970\u20131971","volume":"21","author":"Monath","year":"1972","journal-title":"Nigerian Med J"},{"issue":"9","key":"10.1016\/j.jcv.2014.08.030_bib0115","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pntd.0002435","article-title":"Hospital-based surveillance for viral hemorrhagic fevers and hepatitides in Ghana","volume":"7","author":"Bonney","year":"2013","journal-title":"PLoS Negl Dis"},{"issue":"3","key":"10.1016\/j.jcv.2014.08.030_bib0120","doi-asserted-by":"crossref","first-page":"e1910","DOI":"10.1371\/journal.pntd.0001910","article-title":"Phylogeographic reconstruction of African yellow fever virus isolates indicates recent simultaneous dispersal into East and West Africa","volume":"7","author":"Beck","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4269\/ajtmh.1980.29.929","article-title":"Yellow fever in the Gambia, 1978\u20131979: entomological aspects and epidemiological correlations","volume":"29","author":"Germain","year":"1980","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/JVI.01738-09","article-title":"Yellow fever exhibits slower evolutionary dynamics than dengue virus","volume":"84","author":"Sall","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0135","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1128\/JVI.75.15.6999-7008.2001","article-title":"Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa","volume":"75","author":"Mutebi","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0140","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JVI.01116-12","article-title":"Biological and phylogenetic characteristics of yellow fever virus. Lineages from West Africa","volume":"87","author":"Stock","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0145","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jmv.2078","article-title":"An epidemic of jungle yellow fever in Brazil, 2000. Implications of climatic alterations in disease spread","volume":"65","author":"Vasconcelos","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0150","first-page":"107","article-title":"Les Risques D\u2019\u00c9pid\u00e9misation Urbaine de la Fi\u00e8vre Jaune au Br\u00e9sil par les Vecteurs de la Dengue","volume":"89","author":"Mondet","year":"1996","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.jcv.2014.08.030_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","article-title":"Molecular mechanisms involved in the early steps of Flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jcv.2014.08.030_bib0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"Monath","year":"2003","journal-title":"Adv Virus Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.1752","article-title":"Immunity and immune response, pathology and pathologic changes. Progresses and challenges in the immunopathology of yellow fever","volume":"23","author":"Quaresma","year":"2013","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0175","series-title":"Yellow fever","first-page":"46","article-title":"The virus","author":"Theiler","year":"1951"},{"key":"10.1016\/j.jcv.2014.08.030_bib0180","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). 1. Virologic, biochemical and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.actatropica.2005.03.003","article-title":"Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever","volume":"94","author":"Quaresma","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.jcv.2014.08.030_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","article-title":"Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF\u03b2, TNF\u03b1 and NK cells activity","volume":"345","author":"Quaresma","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2014.08.030_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2005.08.019","article-title":"Immunohistochemical examination of the role of FAS ligand and lymphocytes in the pathogenesis of human liver yellow fever","volume":"116","author":"Quaresma","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.jcv.2014.08.030_bib0200","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.mehy.2006.01.060","article-title":"Midzonal lesion in the yellow fever: a specific pattern of liver injury caused by direct virus action and by immune anti-inflammatory response","volume":"47","author":"Quaresma","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jcv.2014.08.030_bib0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trstmh.2006.02.019","article-title":"Hepatocyte lesions and cellular immune response in yellow fever infection","volume":"101","author":"Quaresma","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.1975.24.115","article-title":"The relative resistance of dengue immune monkeys to yellow fever virus","volume":"24","author":"Theiler","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0220","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4269\/ajtmh.2003.68.695","article-title":"Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses","volume":"68","author":"Xiao","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4269\/ajtmh.1981.30.431","article-title":"Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations in the acute necrosis of B cell areas of lymphoid tissues","volume":"30","author":"Monath","year":"1981","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.jcv.2014.08.030_bib0230","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"ter Meulen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0235a","first-page":"169","article-title":"Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes","volume":"1","author":"Li","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0235b","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0124-00642008000200010","article-title":"Dengue-yellow fever sera cross-reactivity. Challenges for diagnosis","volume":"10","author":"Trivi\u00f1o","year":"2008","journal-title":"Rev Saude P\u00fablica"},{"key":"10.1016\/j.jcv.2014.08.030_bib0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcv.2010.04.013","article-title":"Improved DNA probe based assay for the detection of African and South-American yellow fever virus strains","volume":"48","author":"Weidmann","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0250","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1128\/JCM.01799-12","article-title":"Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories","volume":"50","author":"Domingo","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2011.02.025","article-title":"Evaluation of two molecular methods for the detection of yellow fever virus genome","volume":"174","author":"Nunes","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2014.08.030_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2013.05.004","article-title":"A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus","author":"Kwallah","year":"2013","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.jcv.2014.08.030_bib0265","doi-asserted-by":"crossref","first-page":"e2730","DOI":"10.1371\/journal.pntd.0002730","article-title":"Rapid molecular assays for the detection of yellow fever virus in low-resource settings","volume":"8","author":"Escadafal","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0270","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1016\/j.vaccine.2010.10.070","article-title":"WHO Working Group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13\u201314 May 2009","volume":"28","author":"World Health Organization","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0275","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0280","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0285","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant vaccine against West Nile virus","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcv.2014.08.030_bib0290","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.01775-10","article-title":"Detection of yellow fever 17D genome in urine","volume":"49","author":"Domingo","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcv.2014.01.020","article-title":"An unusual case of influenza-like illness after yellow fever vaccination","volume":"60","author":"Lamson","year":"2014","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.jcv.2014.08.030_bib0300","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS ONE"},{"issue":"June (6)","key":"10.1016\/j.jcv.2014.08.030_bib0305","doi-asserted-by":"crossref","first-page":"e1003458","DOI":"10.1371\/journal.ppat.1003458","article-title":"Dissection of antibody specificities induced by yellow fever vaccination","volume":"9","author":"Vratskikh","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcv.2014.08.030_bib0310","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AEM.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0315","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1016\/j.vaccine.2011.06.034","article-title":"Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model","volume":"29","author":"Julander","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0320","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0325","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"TLR expression and NK cell activation after human yellow fever vaccination","volume":"27","author":"Neves","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0330","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/eji.201142306","article-title":"The early cellular signatures of protective immunity induced by live viral vaccination","volume":"42","author":"Kohler","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0335","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0340","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcv.2014.08.030_bib0345","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcv.2014.08.030_bib0350","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.vaccine.2010.08.046","article-title":"Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults","volume":"29","author":"Silva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0355","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Review article efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0360","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YELLOW FEVER-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0365","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jcv.2014.08.030_bib0370","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0375a","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0375b","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0375c","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2014.08.030_bib0380","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4269\/ajtmh.2010.10-0001","article-title":"Short report: suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States","volume":"82","author":"Monath","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0385","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1016\/j.vaccine.2012.04.067","article-title":"Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"30","author":"Gershman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0390","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the risks and benefits of yellow fever vaccination including some new analyses","volume":"11","author":"Monath","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jcv.2014.08.030_bib0395","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3201\/eid1710.101789","article-title":"Yellow fever virus vaccine\u2014associated deaths in young women","volume":"17","author":"Seligman","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.jcv.2014.08.030_bib0400","doi-asserted-by":"crossref","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcv.2014.08.030_bib0405","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jcv.2014.08.030_bib0410","doi-asserted-by":"crossref","first-page":"e24745","DOI":"10.1371\/journal.pone.0024745","article-title":"Host genetic risk factors for West Nile virus infection and disease progression","volume":"6","author":"Bigham","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0415a","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow-fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2014.08.030_sbref0415b","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2014.08.030_bib0425","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcv.2014.08.030_bib0430","unstructured":"World Health Organization. Detection and investigation of serious adverse events following yellow fever vaccination: guidance from an informal consultation of experts, 18\u201319 November."},{"key":"10.1016\/j.jcv.2014.08.030_bib0435","unstructured":"http:\/\/www.france24.com\/en\/20130706-interview-malcolm-brabant-bbc-correspondent-yellow-fever-vaccination-psychotic-episodes."},{"key":"10.1016\/j.jcv.2014.08.030_bib0445","first-page":"269","article-title":"Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk","volume":"87","author":"Traiber","year":"2011","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.jcv.2014.08.030_bib0450","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1503\/cmaj.100619","article-title":"Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk","volume":"183","author":"Kuhn","year":"2011","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jcv.2014.08.030_bib0455","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcv.2014.08.030_bib0460","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.01635-10","article-title":"Treatment of yellow fever virus with an adenovirus-vectored interferon DEF201, in a hamster model","volume":"55","author":"Julander","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcv.2014.08.030_bib0495","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.2004.71.306","article-title":"Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease","volume":"71","author":"Sbrana","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0465","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.2006.75.333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jcv.2014.08.030_bib0470","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavourable outcome in patients with yellow fever","volume":"190","author":"ter Meulen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0475","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"A clinical trial of an inactivated, cell culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2014.08.030_bib0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-6-3","article-title":"Yellow fever control in Cameroon: where are we now and where are we going?","volume":"6","author":"Wiysonge","year":"2008","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.jcv.2014.08.030_bib0485","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1371\/journal.pntd.0000483","article-title":"Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach","volume":"3","author":"Briand","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jcv.2014.08.030_bib0490","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.vaccine.2013.01.054","article-title":"Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010","volume":"31","author":"Breugelmans","year":"2013","journal-title":"Vaccine"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:56:31Z","timestamp":1598399791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653214003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":99,"alternative-id":["S1386653214003692"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2014.08.030","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yellow fever","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2014.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}